Abstract:Objective: To analyze the de novo point mutations in known genes among patients with unexplained intellectual disability (ID) or developmental retardation (DD). Methods: A total of 120 outpatients with ID or DD were recruited in the Department of Neurology, Affiliated Children's Hospital of Capital Institute of Pediatrics between September 2015 and April 2017. Target gene sequencing was used to screen the candidate gene. The sequencing data were analyzed by a variety of bioinformatics software. Combining with the phenotypes of the patients, the candidate genetic/genomic variants were identified from next-generation sequencing data. The final pathogenicity of the genetic/genomic variants were interpreted according to the guideline of the American College of Medical Genetics and Genomics (ACMG) for variants after segregation analysis in the parents and necessary family members by Sanger sequencing. The comprehensive physiological function and signaling pathways of 20 disease genes with de novo point mutation discovery was also studied. Results: Among the 120 patients, 23 patients were found to carry clear pathological changes, and the incidence of de novo point variation was 19.2%. The patients included 12 males and 11 females, with an age of 2 months to 6-year-6-month. Five patients were diagnosed with early onset of epileptic encephalopathy. Seven had mental retardation type 5, 6, 8, 19, 20, 22, 39, respectively. Weill-Marchesani syndrome type 2 was found in one case, Wiedemann-Steiner syndrome in one case, Coffin-Siris syndrome in two cases, Rubinstein-Taybi syndrome in one case, GLUT1 deficiency syndrome in one case, Rett syndrome in one case, cardio-facio-cutaneous syndrome 3 in one case, neurodegeneration with brain iron accumulation in one case, corpus callosum local dysplasia in one case, and congenital fibrosis of the extra-ocular muscles in one case. A total of 20 novel mutations were reported in this study. No somatic mutation was found in the samples of 6 patients with mutation and their parents' peripheral blood DNA samples by amplicon-based deep sequencing. This study found that the main disease genes were involved in chromatin remodeling, transcriptional regulation, autophagy body assembly, MAPK signal pathway, DNA methylation, potassium, sodium ion transport, cell skeleton assembly and skeletal muscle development. These genes were significantly enriched in the following biological processes: Ras signaling pathways, transcription factor binding and cancer related signaling pathway. Conclusions: The etiology of children affected with intellectual disability or developmental delay is complex. Harmful de novo point mutation plays an important role in these diseases. Targeted exome/genome sequencing based on the core family is helpful for the molecular diagnosis of patients and the discovery of more genes.

A Novel Mutation in a Common Pathogenic Gene (SETD5) Associated with Intellectual Disability: A Case Report.

Novel SETBP1 Mutation in a Chinese Family with Intellectual Disability

Novel SNX13 Frameshift Variant in an Individual with Developmental Delay.

Whole‐exome Sequencing Identified Five Novel De Novo Variants in Patients with Unexplained Intellectual Disability

[Identification of a novel SYNGAP1 mutation in a child with intellectual disability].

Novel PAK3 Gene Missense Variant Associated with Two Chinese Siblings with Intellectual Disability: a Case Report

Mental retardation, seizures and language delay caused by new SETD1B mutations: Three case reports

Identification and functional characterization of de novo variant in the SYNGAP1 gene causing intellectual disability

A novel SETD2 variant causing global development delay without overgrowth in a Chinese 3-year-old boy

Identification of a novel splice mutation in CTNNB1 gene in a Chinese family with both severe intellectual disability and serious visual defects

[Study of de novo point mutations in known genes among patients with unexplained intellectual disability or developmental delay]

A case of intellectual disability reveals a novel mutation in IQSEC2 gene by whole exome sequencing.

Mutation Pattern and Genotype-Phenotype Correlations of SETD2 in Neurodevelopmental Disorders

Case Report: De Novo DDX3X Mutation Caused Intellectual Disability in a Female with Skewed X-chromosome Inactivation on the Mutant Allele.

A Novel Missense ZBTB18 Mutation Identified in an Intellectual Disability Family by Whole Genome Sequencing

Novel mutation identified in CONT3 causes IDDSADF: a case report and literature review

A novel heterozygous ZBTB18 missense mutation in a family with non-syndromic intellectual disability and structural brain abnormalities

Identification of 11 Potentially Relevant Gene Mutations Involved in Growth Retardation, Intellectual Disability, Joint Contracture, and Hepatopathy

[Genetic Analysis of a Pedigree Affected with Intellectual Disability Due to Variants of Two Different Genes].

X-Linked Intellectual Disability, A Novel KDM5C Variation: A Case Report

Identification of a novel METTL23 gene variant in a patient with an intellectual development disorder: a literature review and case report